Moderna

Share

Moderna, Merck move toward filing for personalized melanoma therapy as COVID sales lift Q3 Drug Discovery & Development 4d

Drug Discovery & Development 4d

Merck and Co Pharma

Health Canada approves Moderna’s combined COVID, flu shot for some Global News 4d

Global News 4d

COVID

Other barks & bites for Friday, November 6: Uspto appoints former Newman counsel new solicitor; cafc hears arguments in Moderna’s COVID-19 vaccine appeal; and FTC complaint over amazon’s deceptive ad pricing unsealed IPWatchdog.com 4d

IPWatchdog.com 4d

Moderna, Oxford Uni Ebola jabs backed for pivotal testing pharmaphorum 4d

pharmaphorum 4d

Ebola Pharma

Moderna and GSK settle Spikevax patents dispute Commercial Dispute Resolution 1d

Commercial Dispute Resolution 1d

GSK Pharma

Moderna stock just crashed 21% in a day; Here’s why Finance in Bold 11:30 Fri, 23 Oct

Finance in Bold 11:30 Fri, 23 Oct

Latest

My Sources

Earlier Today

VERDOT Highlights Collaboration with Moderna on Intismeran PRWeb (Press Release) 13:09

Results: Moderna, Inc. Confounded Analyst Expectations With A Surprise Profit Simply Wall St 10:34

Yesterday

Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy The Motley Fool 20:38 Mon, 09 Nov

Can Moderna's First Cancer Therapy Win FDA Approval in 2027? Zacks 19:15 Mon, 09 Nov

Moderna and GSK settle Spikevax patents dispute Commercial Dispute Resolution 18:13 Mon, 09 Nov

Moderna Q3 Earnings Call Highlights Raised Outlook and Oncology Zacks 15:20 Mon, 09 Nov

Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck Zacks 11:26 Mon, 09 Nov

Moderna to relocate its UK HQ to London's Tribeca pharmaphorum 11:05 Mon, 09 Nov

BioNTech vs. Moderna: The Covid Vaccine Giants Are Entering a New Era. One Stock Could Have the Edge for 2027 The Motley Fool 10:28 Mon, 09 Nov

Moderna takes 4,206 sq ft at Tribeca for UK headquarters CRE Herald 08:50 Mon, 09 Nov

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

Moderna Share

Latest

About our Moderna news

Moderna

Share